A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
NCT04673695
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Anticoagulant
Interventions
DRUG:
Lixiana(D006)
DRUG:
CKD-344
Sponsor
Chong Kun Dang Pharmaceutical